Ameriprise Financial »

Celldex Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Celldex Therapeutics (CLDX) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Celldex Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Celldex Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Celldex Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $251k 9.9k 25.27

More positions owned by Ameriprise Financial

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Facebook Inc cl a (META)
iShares S&P 500 Index (IVV)
Visa (V)
Lam Research (LRCX)
Bank of America Corporation (BAC)
Alphabet Inc Class C cs (GOOG)
Wal-Mart Stores (WMT)
Vanguard S&p 500 Etf idx (VOO)

View all positions for Ameriprise Financial

Top funds holding Celldex Therapeutics

Kynam Capital Management
Wellington Management Company
BlackRock
FMR
Vanguard Group
Point72 Asset Management
Bellevue Group
Commodore Capital
State Street Corporation
Deep Track Capital
Eventide Asset Management
Geode Capital Management
Polar Capital Holdings
Pictet Asset Management Holding SA
Vestal Point Capital

View all funds holding Celldex Therapeutics